authors
- Crowther, Mark
- Gold, Alex
- Lu, Genmin
- Leeds, Janet M
- Wiens, Brian L
- Marthur, Vandana
- Castillo, Janice
- Conley, Pamela B
- Connolly, Stuart J
- Curnutte, John T
ANNEXA (TM)-R Part 2: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Sustained Reversal of Rivaroxaban-Induced Anticoagulation in Older Subjects by Andexanet Alfa (PRT064445), a Universal Antidote for Factor XA (FXA) Inhibitors
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- December 8, 2015
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- Circulation Journal